Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma

British Journal of Haematology

Volumn 97, Issue 1, 1997, Pages 29-37

  Wisløff, Finn ^a   Hjorth, Martin ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Lidköping Hospital   (Sweden)

Author keywords

multiple myeloma; multivariate analysis; prognosis; quality of life; questionnaire

Indexed keywords

MELPHALAN; PREDNISONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030935165     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.222667.x     Document Type: Article

References (17)

1. Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., Filiberti, A., Flechtner, S., Fleishman, S.B., de Haes, J.C.J.M., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P.B., Schraub, S., Sneeuw, K., Sullivan, M. & Takeda, F. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376.
2. Altman, D.G., Lausen, B., Sauerbrei, W. & Schumacher, M. (1994) Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. Journal of the National Cancer Institute, 86, 829-835.
3. Anderson J.R., Cain, Kevin C.C. & Gelber, R.D. (1983) Analysis of survival by tumor response. Journal of Clinical Oncology, 1, 710-719.
4. Bladé, J., Lopez-Guillermo, A., Bosch, F., Cervantes, F., Reverter, J.-C., Montserrat, E. & Rozman, C. (1994) Impact of response to treatment on survival in multiple myeloma: results in a series of 243 patients. British Journal of Haematology, 88, 117-121.
5. Coates, A., Gebski, V., Signorini, D., Murray, P., McNeil, D., Byrne, M. & Forbes, J.F. (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Journal of Clinical Oncology, 10, 1833-1838.
6. Fayers, P.M., Aaronson, N.K., Bjordal, K. & Sullivan, M. (1995) EORTC QLQ-C30 Scoring Manual. EORTC Study Group on Quality of Life, Brussels.
7. Ganz, P.A., Lee, J.J. & Siau, J. (1991) Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer, 67, 3131-3135.
8. Kaasa, S., Mastekaasa, A. & Lund, E. (1989) Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiotherapy and Oncology, 15, 235-242.
9. Kyle, R.A. (1994) Why better prognostic factors for multiple myeloma are needed. Blood, 83, 1713-1716.
10. Sorensen, J.B. & Badsberg, J.H. (1990) Prognostic factors in resected stage I and II adenocarcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery, 99, 218-226.
11. Simon, R. & Altman, D.G. (1994) Statistical aspects of prognostic factor studies in oncology. British Journal of Cancer, 69, 979-985.
12. Spiegel, D., Bloom, J.R., Kraemer, H.C. & Gottheil, E. (1989) Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, ii, 888-891.
13. Tamburini, M., Brunella, C., Rosso, S. & Ventafridda, V. (1996) Prognostic value of quality of life scores in terminal cancer patients. Journal of Pain Symptom Management, 1, 32-41.
14. The Nordic Myeloma Study Group (NMSG) (1996) Interferon-alfa-2b added to melphalan-prednisone for initial and maintenance treatment in multiple myeloma: a randomized, controlled trial. Annals of Internal Medicine, 124, 212-222.
15. Weeks, J. (1992) Quality-of life assessment: performance status upstaged? (Editorial). Journal of Clinical Oncology, 10, 1827-1829.
16. Wisløff, F., Eika, S., Hippe, E., Hjorth, M., Holmberg, E., Kaasa, S., Palva, I. & Westin, J. (1996a) Measurement of health-related quality of life in multiple myeloma. British Journal of Haematology, 92, 604-613.
17. Wisløff, F., Hjorth, M., Kaasa, S. & Westin, J. (1996b) Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + α-interferon. British Journal of Haematology, 94, 324-332.